SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001821586-23-000020
Filing Date
2023-11-14
Accepted
2023-11-14 08:01:55
Documents
13
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K mnlk-20231114.htm   iXBRL 8-K 27230
2 EX-99.1 moonlake-pressreleasexq320.htm EX-99.1 120841
  Complete submission text file 0001821586-23-000020.txt   292741

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20231114.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20231114_lab.xml EX-101.LAB 25054
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20231114_pre.xml EX-101.PRE 13017
7 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20231114_htm.xml XML 2913
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 231401664
SIC: 2834 Pharmaceutical Preparations